Gilead Sciences (GILD) Misses Q4 EPS by 27c, Offers FY Guidance
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $138.36 +0.16%
Financial Fact:
Total costs and expenses: 3.1B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total costs and expenses: 3.1B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q4 EPS of $1.44, $0.27 worse than the analyst estimate of $1.71. Revenue for the quarter came in at $5.8 billion versus the consensus estimate of $5.49 billion.
GUIDANCE:
Gilead Sciences sees FY2019 revenue of $21.3-21.8 billion, versus the consensus of $21.74 billion.
- Product Gross Margin 85% - 87%
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Applied Materials (AMAT) Tops Q3 EPS by 10c, Offers Guidance
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
